Why the study?
Streptokinase remains in use for acute STEMI in Malaysian public hospitals, where patients receive a streptokinase card, but a validated tool to evaluate patient knowledge was needed.
A newly developed 9-item Malay language questionnaire is a valid and reliable tool for assessing post-STEMI patients' knowledge about streptokinase therapy and their streptokinase alert cards.
Answers are grounded in this paper and cite their sources.
Enables standardized assessment of streptokinase knowledge in Malay-speaking post-STEMI patients; extends validated tools to regional languages.
Background Although recombinant tissue plasminogen activator has become the first‐line thrombolytic agent, streptokinase remains in use in acute ST‐elevation myocardial infarction (STEMI) patients in Malaysian public hospitals. In a state hospital in Malaysia, all post‐STEMI patients given streptokinase are counselled and issued with a streptokinase card by pharmacists. Due to its highly antigenic nature, knowledge of streptokinase and the streptokinase card serve as an important alert to healthcare providers. This study aimed to develop a validated questionnaire on evaluating knowledge of streptokinase and streptokinase card among post‐STEMI patients. Methods A Malay language questionnaire was developed based on literature review and standard streptokinase counselling checklist. The questionnaire consists of three parts: demographics, knowledge of streptokinase and understanding of streptokinase card. The content of the questionnaire was revised by eight experts (emergency specialists, physicians and pharmacists) and six patients were interviewed via telephone 2 weeks after being issued with a streptokinase card, to test for comprehensibility. Then, a telephone survey was conducted June‐December 2017 involving another 60 patients to test for construct validity and reliability. Results The questionnaire was finalised by decreasing the overall number of items from 6 to 5 (Section B) and 6 to 4 (Section C). The overall measurement of sample adequacy (MSA) was 0.758. Bartlett's test was highly significant (<0.001). The Cronbach's alpha values for Sections B and C were 0.747 and 0.841, respectively. Conclusion Our nine‐item questionnaire is a valid and reliable instrument to assess knowledge of streptokinase and the streptokinase card among Malaysian post‐STEMI patients.
No takes yet. Share an insight, caveat, or question.
Ang et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: